Expedited drug approvals slowed this year as the Food and Drug Administration’s controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and...
The amount of people living in slavery has nearly doubled in the last ten years - despite a near-global consensus that this great evil...
Entrepreneurs, start-ups, and SMEs have to navigate a long road of uncertainty if they dream of ever going public. Throw in the spiking oil...
NFTs continue to rocket into prominence and popularity, with some selling for hundreds of thousands of dollars. Yet the industry is filled with potential...
